Yüklüyor......
NECTIN4: A Novel Therapeutic Target for Melanoma
Malignant melanoma is the most common lethal skin cancer and causes death in a short time when metastasized. Although BRAF inhibitors (BRAFi) have greatly improved the prognosis of BRAF-mutated melanoma, drug resistance is a major concern even when they are combined with MEK inhibitors. Alternative...
Kaydedildi:
| Yayımlandı: | Int J Mol Sci |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7835875/ https://ncbi.nlm.nih.gov/pubmed/33478111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22020976 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|